By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Celldex Therapeutics, Inc. 

222 Cameron Drive
Suite 400
Phillipsburg  New Jersey  08865  U.S.A.
Phone: 908-454-7120 Fax: 908-454-1911


SEARCH JOBS


Industry
Biotechnology






Company News
Theresa LaVallee, Ph.D., Joins Celldex (CLDX)’ Senior Management Team 12/6/2016 8:15:22 AM
Celldex (CLDX) Presents Data On CDX-1140, A Novel CD40 Agonist Antibody For Hematologic And Solid Malignancies, At The American Society of Hematology Annual Meeting 12/5/2016 8:21:50 AM
Celldex (CLDX) Completes Acquisition Of Kolltan Pharma 11/30/2016 8:14:46 AM
Celldex (CLDX) Presents Data On New Product Candidate, CDX-1140, A Novel CD40 Agonist Antibody 11/14/2016 7:53:36 AM
Little Celldex (CLDX) is Sitting on Plenty of Cash and is Ready to Go Shopping 11/8/2016 5:52:59 AM
Celldex (CLDX) Takes Out Kolltan Pharma in $235 Million Deal 11/2/2016 5:42:54 AM
ESMO 2016 Takeaways: Don't Miss Celldex (CLDX), Exelixis (EXEL) and Tesaro (TSRO) 10/12/2016 6:18:55 AM
Celldex (CLDX) Release: Phase II Study Of Single-Agent Glembatumumab Vedotin In Patients With Checkpoint-Refractory Metastatic Melanoma Meets Primary Overall Response Endpoint And Demonstrates Clinically Meaningful Duration Of Response 10/10/2016 8:58:55 AM
Celldex (CLDX) Who? 2 Not-as-Risky Stocks That Shot Up in the Past Year 10/4/2016 6:24:16 AM
Celldex (CLDX) To Present At The Leerink Partners Rare Disease & Immuno-Oncology Roundtable 9/26/2016 8:02:24 AM
12345678910...
//-->